AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) has been approved by the US Food and Drug ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery ...

Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...

Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...

Since the exact cause is not known, it may not be easy to prevent breast cancer. However, reducing the risks of breast cancer ...

(Alliance News) - AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. The Cambridge-based pharmaceuticals firm explained the final approval ...

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...

The market is responding to this breakthrough. Analysts at Exactitude Consultancy predict that the global immunotherapy ...

Scientists at UMass Amherst and Ernest Pharmaceuticals developed BacID, a bacterial cancer therapy activated by aspirin. This ...

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...

Cancer is a significant health challenge worldwide, impacting both developed and developing countries. According to a 2008 ...